VRTX FY 2023 Earnings — Vertex Pharmaceuticals Incorporated Revenue & Financial Results | Market Cap Arena

VRTXVertex Pharmaceuticals Incorporated

$129B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$9.9B+10.5% YoY

Gross Profit

$8.6B87.2% margin

Operating Income

$3.8B38.8% margin

Net Income

$3.6B36.7% margin

EPS (Diluted)

$13.89

Cash Flow

Operating Cash Flow

$3.5B

Free Cash Flow

$3.3B

Stock-Based Comp.

$581M

Balance Sheet

Total Assets

$22.7B

Total Liabilities

$5.1B

Stockholders' Equity

$17.6B

Cash & Equivalents

$10.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.9B	$8.9B	+10.5%
Gross Profit	$8.6B	$7.9B	+9.6%
Operating Income	$3.8B	$4.3B	-11.0%
Net Income	$3.6B	$3.3B	+9.0%